Cases 1 - 10 of 192
Regeneron Pharmaceuticals, Inc. v. Sandoz, Inc.
as 1:2024cv00085
Defendant:
Sandoz Inc.
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2024cv00082
Defendant:
Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Inc.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00067
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
as 1:2024cv00053
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Celltrion, Inc.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Amgen, Inc.
as 1:2024cv00039
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Amgen, Inc.
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified:
AFLIBERCEPT PATENT LITIGATION
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals Inc.
as 1:2024cv00036
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd.
as 1:2023cv00106
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Samsung Bioepis Co., Ltd.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Formycon AG
as 1:2023cv00097
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Formycon AG
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD.,
as 1:2023cv00094
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Samsung Bioepis, CO., LTD.,
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
